BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bordeaux Neurocampus - ECPv4.9.10//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bordeaux Neurocampus
X-ORIGINAL-URL:https://www.bordeaux-neurocampus.fr
X-WR-CALDESC:Évènements pour Bordeaux Neurocampus
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260914T113000
DTEND;TZID=Europe/Paris:20260914T113000
DTSTAMP:20260725T075946
CREATED:20260720T091212Z
LAST-MODIFIED:20260722T161007Z
UID:204935-1789385400-1789385400@www.bordeaux-neurocampus.fr
SUMMARY:Seminar - Ulli Bayer
DESCRIPTION:Venue: Centre Broca \n\nUlli Bayer\nProfessor\nUniversity of Colorado \n \nhttps://medschool.cuanschutz.edu/pharmacology/faculty/primary-faculty/ulli-bayer-phd \nInvited by Daniel Choquet \nTitle\nCaMKII in LTP\, Alzheimer’s disease\, and beyond \nBio\nUlli Bayer started working on CaMKII as a graduate student in Hamburg\, Germany. He continued working on CaMKII throughout his PostDoc at Stanford and in his own lab at CU Anschutz\, where he rose through the ranks to tenured full professor. In Ulli’s lab\, the focus is on (i) functions in synaptic plasticity\, (ii) how it goes wrong in disease\, and (iii) how to fix it. The diseases of interest range from Alzheimer’s to stroke\, but all involve the CaMKII interplay with the NMDA type glutamate receptor subunit GluN2B. \n
URL:https://www.bordeaux-neurocampus.fr/event/seminar-ulli-bayer/
CATEGORIES:A la une,Pour les scientifiques,Séminaire Impromptu
END:VEVENT
END:VCALENDAR